政大機構典藏-National Chengchi University Institutional Repository(NCCUR):Item 140.119/154534
English  |  正體中文  |  简体中文  |  Post-Print筆數 : 27 |  Items with full text/Total items : 113656/144643 (79%)
Visitors : 51733699      Online Users : 594
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    政大典藏 > College of Law > Periodical Articles >  Item 140.119/154534
    Please use this identifier to cite or link to this item: https://nccur.lib.nccu.edu.tw/handle/140.119/154534


    Title: Reconsidering Conflicts over Gene Patents in view of Taiwan Patent Law
    Authors: 陳龍昇
    Chen, Lung-Sheng
    Contributors: 法學院
    Keywords: gene patent;compulsory license;Myriad;research exemption;Taiwan Patent Act;patient access;patent eligibility
    Date: 2020-04
    Issue Date: 2024-11-29 14:04:02 (UTC+8)
    Abstract: This article discusses the legal and policy issues arising out of gene patents in light of the United States Supreme Court's Myriad decision. There are alternatives to an outright ban on all gene patents. This article proposes recommendations to accommodate the competing interests of patient access to beneficial technologies and gene patenting. In order to balance the competing interests of encouraging innovation while making gene-based medical treatment more accessible, a research exemption from patent infringement and compulsory licensing of a gene patent is suggested by referring to the Taiwan Patent Act. These solutions would ensure scientists and other groups the opportunity to use gene-related patents for the public interest or noncommercial purposes. The research exemption enables research on patented genes without the risk of being held liable for infringement, thereby promoting further advancement in the gene-related industry. The framework of a compulsory license ensures patient access to genetic treatment. These solutions, on the one hand, solve primary concerns surrounding gene patents, and on the other hand, maintain gene patent protection and the incentives needed to promote the progress of gene-related technologies.
    Relation: Biotechnology Law Report, Vol.39, No.2, pp.100-112
    Data Type: article
    DOI link: https://doi.org/10.1089/blr.2020.29162.lsc
    DOI: 10.1089/blr.2020.29162.lsc
    Appears in Collections:[College of Law] Periodical Articles

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML22View/Open


    All items in 政大典藏 are protected by copyright, with all rights reserved.


    社群 sharing

    著作權政策宣告 Copyright Announcement
    1.本網站之數位內容為國立政治大學所收錄之機構典藏,無償提供學術研究與公眾教育等公益性使用,惟仍請適度,合理使用本網站之內容,以尊重著作權人之權益。商業上之利用,則請先取得著作權人之授權。
    The digital content of this website is part of National Chengchi University Institutional Repository. It provides free access to academic research and public education for non-commercial use. Please utilize it in a proper and reasonable manner and respect the rights of copyright owners. For commercial use, please obtain authorization from the copyright owner in advance.

    2.本網站之製作,已盡力防止侵害著作權人之權益,如仍發現本網站之數位內容有侵害著作權人權益情事者,請權利人通知本網站維護人員(nccur@nccu.edu.tw),維護人員將立即採取移除該數位著作等補救措施。
    NCCU Institutional Repository is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff(nccur@nccu.edu.tw). We will remove the work from the repository and investigate your claim.
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback